Knox Lane agrees $437m acquisition of US healthcare staffing firm Cross Country Healthcare

US healthcare workforce solutions company Cross Country Healthcare has agreed to be acquired by growth-focused investment firm Knox Lane in a transaction worth approximately $437 million (€369 million), taking the Nasdaq-listed staffing specialist private in a deal that carries a significant premium to its recent trading price.

According to Guru Focus, Knox Lane will pay $13.25 (€11.18) per share for all outstanding common stock, representing a premium of approximately 31% to Cross Country Healthcare's closing share price on 6 May and a 45% premium relative to the company's weighted average trading price over the preceding 90 days.

Cross Country Healthcare operates an AI-powered digital platform alongside advisory services designed to help health systems manage their labour ecosystems across two business segments: Nursing and Allied Staffing, and Physician Staffing. The company provides staffing, recruiting and workforce solutions to healthcare organisations across the United States.

The acquisition gives Knox Lane a direct presence in the healthcare workforce solutions market at a time when health systems are under sustained pressure to manage labour costs and staffing complexity. Technology-enabled staffing platforms have attracted growing investor attention as hospitals and health networks seek more efficient alternatives to traditional agency models.

Cross Country Healthcare carries a market capitalisation of approximately $544 million (€459 million). The premium agreed by Knox Lane signals the acquiring firm's confidence in the underlying value of Cross Country Healthcare's platform and its growth trajectory within an increasingly technology-dependent healthcare staffing environment.

No timeline for completion was disclosed in the announcement, nor were specific conditions attached to the transaction outlined in detail.

Read the full analysis of the Cross Country Healthcare acquisition to learn more.